Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 265

1.

Acute promyelocytic leukemia with a cryptic insertion of RARA into TBL1XR1.

Osumi T, Watanabe A, Okamura K, Nakabayashi K, Yoshida M, Tsujimoto SI, Uchiyama M, Takahashi H, Tomizawa D, Hata K, Kiyokawa N, Kato M.

Genes Chromosomes Cancer. 2019 Nov;58(11):820-823. doi: 10.1002/gcc.22791. Epub 2019 Aug 10.

PMID:
31350930
2.

A novel KMT2A-ACTN2 fusion in infant B-cell acute lymphoblastic leukemia.

Yoshida M, Nakabayashi K, Ogata-Kawata H, Osumi T, Tsujimoto SI, Shirai R, Yoshida K, Okamura K, Matsumoto K, Kiyokawa N, Tomizawa D, Hata K, Kato M.

Pediatr Blood Cancer. 2019 Aug;66(8):e27821. doi: 10.1002/pbc.27821. Epub 2019 May 21. No abstract available.

PMID:
31115144
3.

Age-related analysis of the gut microbiome in a purebred dog colony.

Mizukami K, Uchiyama J, Igarashi H, Murakami H, Osumi T, Shima A, Ishiahra G, Nasukawa T, Une Y, Sakaguchi M.

FEMS Microbiol Lett. 2019 Apr 1;366(8). pii: fnz095. doi: 10.1093/femsle/fnz095.

PMID:
31049554
4.

Whole transcriptome sequencing reveals a KMT2A-USP2 fusion in infant acute myeloid leukemia.

Ikeda J, Shiba N, Tsujimoto SI, Yoshida M, Nakabayashi K, Ogata-Kawata H, Okamura K, Takeuchi M, Osumi T, Tomizawa D, Hata K, Kiyokawa N, Ito S, Kato M.

Genes Chromosomes Cancer. 2019 Sep;58(9):669-672. doi: 10.1002/gcc.22751. Epub 2019 Apr 8.

PMID:
30869817
5.

Successful Treatment With ATRA and Arsenic Trioxide for a Child With Down Syndrome and Acute Promyelocytic Leukemia.

Tsumura Y, Yamada Y, Osumi T, Kato M, Terashima K, Shioda Y, Kiyotani C, Matsumoto K, Tomizawa D.

J Pediatr Hematol Oncol. 2019 Feb 22. doi: 10.1097/MPH.0000000000001438. [Epub ahead of print]

PMID:
30807394
6.

Pathogenic mutations identified by a multimodality approach in 117 Japanese Fanconi anemia patients.

Mori M, Hira A, Yoshida K, Muramatsu H, Okuno Y, Shiraishi Y, Anmae M, Yasuda J, Tadaka S, Kinoshita K, Osumi T, Noguchi Y, Adachi S, Kobayashi R, Kawabata H, Imai K, Morio T, Tamura K, Takaori-Kondo A, Yamamoto M, Miyano S, Kojima S, Ito E, Ogawa S, Matsuo K, Yabe H, Yabe M, Takata M.

Haematologica. 2019 Oct;104(10):1962-1973. doi: 10.3324/haematol.2018.207241. Epub 2019 Feb 21.

7.

Machiavellianism and early neural responses to others' facial expressions caused by one's own decisions.

Osumi T, Tsuji K, Shibata M, Umeda S.

Psychiatry Res. 2019 Jan;271:669-677. doi: 10.1016/j.psychres.2018.12.037. Epub 2018 Dec 6.

PMID:
30791340
8.

A double-blind, placebo-controlled evaluation of orally administered heat-killed Enterococcus faecalis FK-23 preparation in atopic dogs.

Osumi T, Shimada T, Sakaguchi M, Tsujimoto H.

Vet Dermatol. 2019 Apr;30(2):127-e36. doi: 10.1111/vde.12725. Epub 2019 Jan 20.

PMID:
30663154
9.

First identification of a single amino acid change in the spike protein region of feline coronavirus detected from a coronavirus-associated cutaneous nodule in a cat.

Osumi T, Mitsui I, Leutenegger CM, Okabe R, Ide K, Nishifuji K.

JFMS Open Rep. 2018 Sep 20;4(2):2055116918801385. doi: 10.1177/2055116918801385. eCollection 2018 Jul-Dec.

10.

B-lymphoblastic lymphoma with TCF3-PBX1 fusion gene.

Kubota-Tanaka M, Osumi T, Miura S, Tsujimoto H, Imamura T, Nishimura A, Oki K, Nakamura K, Miyamoto S, Inoue K, Inoue M, Kamiya T, Yanagimachi M, Okano T, Mitsuiki N, Isoda T, Imai K, Kanegane H, Morio T, Kounami S, Endo M, Kato M, Takagi M.

Haematologica. 2019 Jan;104(1):e35-e37. doi: 10.3324/haematol.2018.199885. Epub 2018 Sep 27. No abstract available.

11.

The Effect of Interim FDG-PET-guided Response-Adapted Therapy in Pediatric Patients with Hodgkin's Lymphoma (HL-14) : Protocol for a Phase II Study.

Koga Y, Baba S, Fukano R, Nakamura K, Soejima T, Maeda N, Sunami S, Ueyama J, Mitsui T, Mori T, Osumi T, Sekimizu M, Ohki K, Tanaka F, Kamei M, Fujita N, Mori T, Saito AM, Kada A, Kobayashi R.

Acta Med Okayama. 2018 Aug;72(4):437-440. doi: 10.18926/AMO/56185.

13.

Preoperative diagnosis of clear cell sarcoma of the kidney by detection of BCOR internal tandem duplication in circulating tumor DNA.

Ueno-Yokohata H, Okita H, Nakasato K, Hishiki T, Shirai R, Tsujimoto S, Osumi T, Yoshimura S, Yamada Y, Shioda Y, Kiyotani C, Terashima K, Miyazaki O, Matsumoto K, Kiyokawa N, Yoshioka T, Kato M.

Genes Chromosomes Cancer. 2018 Oct;57(10):525-529. doi: 10.1002/gcc.22648. Epub 2018 Aug 20.

PMID:
30126017
14.

Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms.

Tsujimoto S, Osumi T, Uchiyama M, Shirai R, Moriyama T, Nishii R, Yamada Y, Kudo K, Sekiguchi M, Arakawa Y, Yoshida M, Uchiyama T, Terui K, Ito S, Koh K, Takita J, Ito E, Tomizawa D, Manabe A, Kiyokawa N, Yang JJ, Kato M.

Leukemia. 2018 Dec;32(12):2710-2714. doi: 10.1038/s41375-018-0190-1. Epub 2018 Jul 2. No abstract available.

15.

A prospective study of allogeneic transplantation from unrelated donors for chronic granulomatous disease with target busulfan-based reduced-intensity conditioning.

Osumi T, Tomizawa D, Kawai T, Sako M, Inoue E, Takimoto T, Tamura E, Uchiyama T, Imadome KI, Taniguchi M, Shirai R, Yoshida M, Ando R, Tsumura Y, Fuji H, Matsumoto K, Shioda Y, Kiyotani C, Terashima K, Onodera M, Matsumoto K, Kato M.

Bone Marrow Transplant. 2019 Jan;54(1):168-172. doi: 10.1038/s41409-018-0271-9. Epub 2018 Jun 29. No abstract available.

PMID:
29959437
16.

Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation.

Osumi T, Tsujimoto SI, Tamura M, Uchiyama M, Nakabayashi K, Okamura K, Yoshida M, Tomizawa D, Watanabe A, Takahashi H, Hori T, Yamamoto S, Hamamoto K, Migita M, Ogata-Kawata H, Uchiyama T, Kizawa H, Ueno-Yokohata H, Shirai R, Seki M, Ohki K, Takita J, Inukai T, Ogawa S, Kitamura T, Matsumoto K, Hata K, Kiyokawa N, Goyama S, Kato M.

Cancer Res. 2018 Aug 15;78(16):4452-4458. doi: 10.1158/0008-5472.CAN-18-0840. Epub 2018 Jun 19.

17.

Collagen-enriched serpiginous skin lesion in a cat resembling the linear form of localized scleroderma in humans.

Osumi T, Mitsui I, Morita A, Iyori K, Nishifuji K.

J Vet Med Sci. 2018 Jul 12;80(7):1077-1079. doi: 10.1292/jvms.18-0128. Epub 2018 May 23.

18.

Successful treatment of systemic EBV positive T-cell lymphoma of childhood using the SMILE regimen.

Yoshida M, Osumi T, Imadome KI, Tomizawa D, Kato M, Miyazawa N, Ito R, Nakazawa A, Matsumoto K.

Pediatr Hematol Oncol. 2018 Mar;35(2):121-124. doi: 10.1080/08880018.2018.1459982. Epub 2018 Apr 12. No abstract available.

PMID:
29648917
19.

Somatic MECOM mosaicism in a patient with congenital bone marrow failure without a radial abnormality.

Osumi T, Tsujimoto SI, Nakabayashi K, Taniguchi M, Shirai R, Yoshida M, Uchiyama T, Nagasawa J, Goyama S, Yoshioka T, Tomizawa D, Kurokawa M, Matsubara Y, Kiyokawa N, Matsumoto K, Hata K, Kato M.

Pediatr Blood Cancer. 2018 Jun;65(6):e26959. doi: 10.1002/pbc.26959. Epub 2018 Jan 22. No abstract available.

PMID:
29356389
20.

A Cryptic NUP214-ABL1 Fusion in B-cell Precursor Acute Lymphoblastic Leukemia.

Tsujimoto SI, Nakano Y, Osumi T, Okada K, Ouchi-Uchiyama M, Kataoka K, Fujii Y, Ohki K, Seki M, Tamagawa N, Takita J, Ogawa S, Kiyokawa N, Hara J, Kato M.

J Pediatr Hematol Oncol. 2018 Aug;40(6):e397-e399. doi: 10.1097/MPH.0000000000001007.

PMID:
29219890
21.

Selective Fair Behavior as a Function of Psychopathic Traits in a Subclinical Population.

Osumi T, Ohira H.

Front Psychol. 2017 Sep 13;8:1604. doi: 10.3389/fpsyg.2017.01604. eCollection 2017.

22.

Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation.

Yamazaki F, Shima H, Osumi T, Narumi S, Kuroda T, Shimada H.

J Pediatr Hematol Oncol. 2018 Apr;40(3):e195-e197. doi: 10.1097/MPH.0000000000000948.

PMID:
28902083
23.

Pediatric follicular lymphoma in Japan.

Kobayashi R, Tanaka F, Nakazawa A, Ueyama JI, Sunami S, Mitsui T, Koga Y, Mori T, Osumi T, Fukano R, Ohki K, Sekimizu M, Fujita N, Kamei M, Mori T; Lymphoma Committee and Japanese Pediatric Leukemia/Lymphoma Study Group.

Int J Hematol. 2017 Jun;105(6):849-853. doi: 10.1007/s12185-017-2209-1. Epub 2017 Mar 7.

PMID:
28271414
24.

Blastic transformation of juvenile myelomonocytic leukemia caused by the copy number gain of oncogenic KRAS.

Osumi T, Kato M, Ouchi-Uchiyama M, Tomizawa D, Kataoka K, Fujii Y, Seki M, Takita J, Ogawa S, Uchiyama T, Ohki K, Kiyokawa N.

Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26496. Epub 2017 Feb 28.

PMID:
28244637
25.

Time course and localization of brain activity in humor comprehension: An ERP/sLORETA study.

Shibata M, Terasawa Y, Osumi T, Masui K, Ito Y, Sato A, Umeda S.

Brain Res. 2017 Feb 15;1657:215-222. doi: 10.1016/j.brainres.2016.12.010. Epub 2016 Dec 19.

PMID:
28007611
26.

Transmission of chromosomally integrated human herpesvirus 6 via cord blood transplantation.

Yamada Y, Osumi T, Imadome KI, Takahashi E, Ohye T, Yoshikawa T, Tomizawa D, Kato M, Matsumoto K.

Transpl Infect Dis. 2017 Feb;19(1). doi: 10.1111/tid.12636. Epub 2016 Dec 25.

PMID:
27859994
27.

Primary mediastinal large B-cell lymphoma in Japanese children and adolescents.

Osumi T, Tanaka F, Mori T, Fukano R, Tsurusawa M, Oshima K, Nakazawa A, Kobayashi R.

Int J Hematol. 2017 Apr;105(4):440-444. doi: 10.1007/s12185-016-2147-3. Epub 2016 Nov 17.

PMID:
27858330
28.

Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation.

Kobayashi R, Mitsui T, Fujita N, Osumi T, Aoki T, Aoki K, Suzuki R, Fukuda T, Miyamoto T, Kato K, Nakamae H, Goto H, Eto T, Inoue M, Mori T, Terui K, Onizuka M, Koh K, Koga Y, Ichinohe T, Sawada A, Atsuta Y, Suzumiya J.

Int J Hematol. 2017 Mar;105(3):369-376. doi: 10.1007/s12185-016-2120-1. Epub 2016 Oct 27.

PMID:
27787746
29.

Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children.

Kato M, Ishimaru S, Seki M, Yoshida K, Shiraishi Y, Chiba K, Kakiuchi N, Sato Y, Ueno H, Tanaka H, Inukai T, Tomizawa D, Hasegawa D, Osumi T, Arakawa Y, Aoki T, Okuya M, Kaizu K, Kato K, Taneyama Y, Goto H, Taki T, Takagi M, Sanada M, Koh K, Takita J, Miyano S, Ogawa S, Ohara A, Tsuchida M, Manabe A.

Leukemia. 2017 Mar;31(3):580-584. doi: 10.1038/leu.2016.274. Epub 2016 Oct 4.

PMID:
27698447
30.

Heart-rate deceleration predicting the determination of costly punishment: Implications for its involvement in cognitive effort expended in overriding self-interest.

Osumi T, Ohira H.

Int J Psychophysiol. 2016 Nov;109:29-36. doi: 10.1016/j.ijpsycho.2016.09.017. Epub 2016 Sep 28.

PMID:
27693101
31.

ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.

Hirabayashi S, Ohki K, Nakabayashi K, Ichikawa H, Momozawa Y, Okamura K, Yaguchi A, Terada K, Saito Y, Yoshimi A, Ogata-Kawata H, Sakamoto H, Kato M, Fujimura J, Hino M, Kinoshita A, Kakuda H, Kurosawa H, Kato K, Kajiwara R, Moriwaki K, Morimoto T, Nakamura K, Noguchi Y, Osumi T, Sakashita K, Takita J, Yuza Y, Matsuda K, Yoshida T, Matsumoto K, Hata K, Kubo M, Matsubara Y, Fukushima T, Koh K, Manabe A, Ohara A, Kiyokawa N; Tokyo Children’s Cancer Study Group (TCCSG).

Haematologica. 2017 Jan;102(1):118-129. doi: 10.3324/haematol.2016.151035. Epub 2016 Sep 15.

32.

Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents.

Attarbaschi A, Carraro E, Abla O, Barzilai-Birenboim S, Bomken S, Brugieres L, Bubanska E, Burkhardt B, Chiang AK, Csoka M, Fedorova A, Jazbec J, Kabickova E, Krenova Z, Lazic J, Loeffen J, Mann G, Niggli F, Miakova N, Osumi T, Ronceray L, Uyttebroeck A, Williams D, Woessmann W, Wrobel G, Pillon M; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the International Berlin-Frankfur t-Münster (i-BFM) Study Group.

Haematologica. 2016 Dec;101(12):1581-1591. Epub 2016 Aug 11.

33.

Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.

Osumi T, Mori T, Fujita N, Saito AM, Nakazawa A, Tsurusawa M, Kobayashi R.

Pediatr Blood Cancer. 2016 Oct;63(10):1794-9. doi: 10.1002/pbc.26105. Epub 2016 Jun 17.

PMID:
27314926
34.

[LMB chemotherapy for mature B-cell neoplasms in children: a single-center experience].

Osumi T, Mori T, Shioda Y, Kiyotani C, Terashima K, Kato M, Tomizawa D, Ohki K, Kiyokawa N, Iwafuchi H, Yoshioka T, Nakazawa A, Matsumoto K.

Rinsho Ketsueki. 2016 Mar;57(3):346-52. doi: 10.11406/rinketsu.57.346. Japanese.

PMID:
27076248
35.

Transcription Factor hDREF Is a Novel SUMO E3 Ligase of Mi2α.

Yamashita D, Moriuchi T, Osumi T, Hirose F.

J Biol Chem. 2016 May 27;291(22):11619-34. doi: 10.1074/jbc.M115.713370. Epub 2016 Apr 11.

36.

Lamin A reassembly at the end of mitosis is regulated by its SUMO-interacting motif.

Moriuchi T, Kuroda M, Kusumoto F, Osumi T, Hirose F.

Exp Cell Res. 2016 Mar 1;342(1):83-94. doi: 10.1016/j.yexcr.2016.02.016. Epub 2016 Feb 24.

PMID:
26921507
37.

Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group.

Keino D, Kinoshita A, Tomizawa D, Takahashi H, Ida K, Kurosawa H, Koike K, Ota S, Iwasaki N, Fujimura J, Yuza Y, Kiyotani C, Yamamoto S, Osumi T, Ueda T, Mochizuki S, Isoyama K, Hanada R, Tawa A, Manabe A, Toguchi Y, Ohara A.

Int J Hematol. 2016 Apr;103(4):416-22. doi: 10.1007/s12185-016-1937-y. Epub 2016 Jan 18.

PMID:
26781613
38.

Heart lipid droplets and lipid droplet-binding proteins: Biochemistry, physiology, and pathology.

Osumi T, Kuramoto K.

Exp Cell Res. 2016 Jan 15;340(2):198-204. doi: 10.1016/j.yexcr.2015.10.031. Epub 2015 Oct 30. Review. No abstract available.

PMID:
26524506
39.

Conformation of carboxylated schizophyllan in aqueous solution.

Yoshiba K, Sato T, Osumi T, Ulset AS, Christensen BE.

Carbohydr Polym. 2015 Dec 10;134:1-5. doi: 10.1016/j.carbpol.2015.07.049. Epub 2015 Jul 21.

PMID:
26428092
40.

Treatment of pediatric lymphoma in Japan: Current status and plans for the future.

Kobayashi R, Sunami S, Mitsui T, Nakazawa A, Koga Y, Mori T, Tanaka F, Ueyama J, Osumi T, Fukano R, Ohki K, Sekimizu M, Mori T; Lymphoma Committee; Japanese Pediatric Leukemia/Lymphoma Study Group.

Pediatr Int. 2015 Aug;57(4):523-34. doi: 10.1111/ped.12725. Review.

PMID:
26096060
41.

A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia.

Gocho Y, Kiyokawa N, Ichikawa H, Nakabayashi K, Osumi T, Ishibashi T, Ueno H, Terada K, Oboki K, Sakamoto H, Shioda Y, Imai M, Noguchi Y, Arakawa Y, Kojima Y, Toyama D, Hata K, Yoshida T, Matsumoto K, Kato M, Fukushima T, Koh K, Manabe A, Ohara A; Tokyo Children’s Cancer Study Group.

Leukemia. 2015 Dec;29(12):2445-8. doi: 10.1038/leu.2015.111. Epub 2015 May 6. No abstract available.

PMID:
25943178
42.

Successful treatment of metastatic rhabdomyosarcoma with radiochemotherapy and allogeneic hematopoietic stem cell transplantation.

Yamazaki F, Osumi T, Shigematsu N, Morioka H, Shimada H.

Jpn J Clin Oncol. 2015 Feb;45(2):225-8. doi: 10.1093/jjco/hyu189. Epub 2014 Nov 14.

PMID:
25398582
43.

Epstein-Barr virus (EBV)-positive sporadic burkitt lymphoma: an age-related lymphoproliferative disorder?

Satou A, Asano N, Nakazawa A, Osumi T, Tsurusawa M, Ishiguro A, Elsayed AA, Nakamura N, Ohshima K, Kinoshita T, Nakamura S.

Am J Surg Pathol. 2015 Feb;39(2):227-35. doi: 10.1097/PAS.0000000000000332.

PMID:
25321330
44.

Long-term expression of the lamin A mutant associated with dilated cardiomyopathy induces senescence.

Moriuchi T, Muraoka T, Mio K, Osumi T, Hirose F.

Genes Cells. 2014 Dec;19(12):901-18. doi: 10.1111/gtc.12189. Epub 2014 Oct 16.

45.

Single-cell cloning and expansion of human induced pluripotent stem cells by a microfluidic culture device.

Matsumura T, Tatsumi K, Noda Y, Nakanishi N, Okonogi A, Hirano K, Li L, Osumi T, Tada T, Kotera H.

Biochem Biophys Res Commun. 2014 Oct 10;453(1):131-7. doi: 10.1016/j.bbrc.2014.09.081. Epub 2014 Sep 27.

PMID:
25264198
46.

Deficiency of a lipid droplet protein, perilipin 5, suppresses myocardial lipid accumulation, thereby preventing type 1 diabetes-induced heart malfunction.

Kuramoto K, Sakai F, Yoshinori N, Nakamura TY, Wakabayashi S, Kojidani T, Haraguchi T, Hirose F, Osumi T.

Mol Cell Biol. 2014 Jul;34(14):2721-31.

47.

Metabolic conversion of C20 polymethylene-interrupted polyunsaturated fatty acids to essential fatty acids.

Tanaka T, Uozumi S, Morito K, Osumi T, Tokumura A.

Lipids. 2014 May;49(5):423-9.

PMID:
24659112
48.

Recommendations and best practices for reference standards and reagents used in bioanalytical method validation.

Bower JF, McClung JB, Watson C, Osumi T, Pastre K.

AAPS J. 2014 Mar;16(2):352-6. doi: 10.1208/s12248-014-9566-y. Epub 2014 Feb 6.

49.

Sensitivity of SNX2-ABL1 toward tyrosine kinase inhibitors distinct from that of BCR-ABL1.

Tomita O, Iijima K, Ishibashi T, Osumi T, Kobayashi K, Okita H, Saito M, Mori T, Shimizu T, Kiyokawa N.

Leuk Res. 2014 Mar;38(3):361-70. doi: 10.1016/j.leukres.2013.11.017. Epub 2013 Dec 1.

PMID:
24367893
50.

Poor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia with SNX2-ABL1 chimeric transcript.

Masuzawa A, Kiyotani C, Osumi T, Shioda Y, Iijima K, Tomita O, Nakabayashi K, Oboki K, Yasuda K, Sakamoto H, Ichikawa H, Hata K, Yoshida T, Matsumoto K, Kiyokawa N, Mori T.

Eur J Haematol. 2014 Mar;92(3):263-7. doi: 10.1111/ejh.12234. Epub 2013 Nov 28.

PMID:
24215620

Supplemental Content

Support Center